CClinicalTrials.gg
CompletedNCT02647021TARGETUpdated Jan 3, 2024

Therapeutic Resistance Group Exercise Training for Head & Neck Cancer Survivors

An interventional study of Therapeutic Exercise and Therapeutic + Lower Body Exercise in Head and Neck Neoplasms, Accessory Nerve Injury and Fatigue, sponsored by University of Alberta. Completed at 1 site in Canada. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-01-03.

Sponsored by University of Alberta · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The investigators will conduct a randomized controlled trial examining 12-week, 24-week and one year outcomes from a combined therapeutic and physical exercise program that aims to bridge head-and-neck cancer survivors from acute care rehabilitation services to community-based exercise programming.

Read the detailed description

Participants will be stratified by early (within 18 months of surgery) and late (> 18 months of surgery) and randomized on a one-on-one basis to (1) a supervised therapeutic exercise program for the neck and shoulder (serving as standard care) or (2) a combined therapeutic and lower body resistance exercise program. The randomization sequence will be generated by staff in the Rehabilitation Research Centre at Corbett Hall and placed in sealed opaque envelopes.

The exercise program will be offered in a group setting. Participants will exercise 2 times per week for a 10-week session and will have the option to continue for an additional 10-week maintenance session. The primary outcome for the study will be quality of life as measured by the Functional Assessment of Cancer Therapy (FACT)-Fatigue Scale at 12-weeks.

At each measurement point following the baseline assessment, including the 12-week and 24-week and one year follow-ups, an Independent Assessor will perform the objective fitness measurements. The Independent Assessor will also administer the Neck Dissection Impairment Questionnaire and the FACT-Fatigue quality of life questionnaires. The Physical Activity Adherence Diary will be collected by a Research Coordinator at each follow-up visit.

02

Conditions studied

  • Head and Neck Neoplasms
  • Accessory Nerve Injury
  • Fatigue

Keywords

  • physical therapy
  • cancer rehabilitation
  • exercise
03

In context

Head and Neck Neoplasms

2,344 studies on the registry are indexed under Head and Neck Neoplasms; 551 are open to participants now.

This study's enrollment of 60 is above the median of 47 across 1,751 interventional studies indexed under Head and Neck Neoplasms.

Browse Head and Neck Neoplasms studies →

Lead sponsor

University of Alberta is the lead sponsor of 800 studies on the registry; 168 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Squamous cell carcinoma/ thyroid cancer/ melanoma or lymphoma involving: oral cavity, oropharynx, larynx or hypopharynx, or lymph nodes in the neck region
  • Surgical treatment includes radical neck dissection, modified radical neck dissection and other variants of functional/selective neck dissection OR radiation therapy to lymph node regions
  • Presenting with shoulder and/ or neck dysfunction related to cancer treatment
  • Karnofsky Performance Status greater than or equal to 60%
  • No evidence of residual cancer in the neck and no distant (M0) metastasis. Potential participants with symptoms suggestive of distant metastasis (M1) must have appropriate investigations (e.g. bone scan) to rule these out.
  • Participants must have completed their head and neck/ thyroid/ melanoma/ lymphoma cancer treatment (minimum 4 weeks post treatment)
  • Pre-participation Screening: Prior to participation in the exercise program, potential participants will complete general and cancer-specific Physical Activity Readiness Questionnaires (PAR-Q+) to determine appropriateness for the exercise program. Physician consent and approval for supervised exercise will be required prior to enrollment.

Exclusion criteria

Exclusion Criteria:

  • A participant will be ineligible if they present with medical illness or psychiatric illness, which, in the opinion of the investigators, would impact his/her ability to participate in exercise or interfere with follow-up.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
60 participants (actual)

Study arms

  • Active comparator
    Therapeutic Exercise

    Therapeutic Exercise Program (standard care) will include: 1. Neck range of motion and strengthening, and posture retraining. 2. Shoulder specific progressive resistance exercise program that focuses on spinal accessory nerve dysfunction and rehabilitation of trapezius muscle function.

    Behavioral: Therapeutic Exercise

  • Experimental
    Therapeutic + Lower Body Exercise

    The Therapeutic Exercise Program (standard care) will include: 1. Neck range of motion and strengthening, and posture retraining. 2. Shoulder specific progressive resistance exercise program that focuses on spinal accessory nerve dysfunction and rehabilitation of trapezius muscle function. The Resistance Exercise component will target 6-8 muscle groups of the lower extremities and core including gluteal, quadriceps, hamstrings, abdominals, and gastrocnemius muscles. A progressive introduction of exercises will occur over the first 3 weeks. 1. a personalized program of lower extremity resistance exercises 2. core strengthening exercises

    Behavioral: Therapeutic Exercise · Behavioral: Therapeutic + Lower Body Exercise

Interventions

  • BehavioralTherapeutic Exercise

    A specialized therapeutic exercise program to address neck and shoulder dysfunction due to spinal accessory nerve damage.

  • BehavioralTherapeutic + Lower Body Exercise

    A combined therapeutic exercise program (as per the comparison arm) plus the addition of lower body resistance exercise

06

What researchers measure

Primary outcomes

  1. Functional Assessment of Cancer Therapy: Fatigue Scale Questionnaire

    Cancer related fatigue

    Time frame: change from baseline to 12 weeks.

Secondary outcomes

  1. Shoulder range of motion in degrees.

    Active and passive glenohumeral joint range of motion using standard 12 inch goniometer.

    Time frame: Change from baseline to one year

  2. Body mass index

    Derived from height and weight of the participant.

    Time frame: Change from baseline to 24 weeks.

  3. 1 repetition maximum (1RM) strength for seated row in pounds.

    The maximal amount weight that can be pulled (seated row) and pushed (vertical bench) with proper form.

    Time frame: Change from baseline to 12 weeks.

  4. Neck Range of Motion in degrees.

    Measures of neck flexion, side flexion, rotations and extension using myrin goniometer.

    Time frame: Change from baseline to 12 weeks.

  5. Upper extremity muscular endurance: number of repetitions performed.

    Maximal repetitions to fatigue based on 50% of 1 repetition maximum strength for seated row.

    Time frame: baseline, 12-weeks, 24-weeks, one year

  6. Lower extremity flexibility in centimetres.

    Sit and reach test

    Time frame: Change from baseline to 12-weeks.

  7. Functional capacity

    6 minute walk test

    Time frame: Change from baseline to 24 weeks.

  8. Neck Dissection Impairment Index

    Neck dissection related quality of life

    Time frame: Change from baseline to one year.

  9. Grip strength in pounds.

    Maximal grip strength: composite score of both hands. Best of three attempts for each side.

    Time frame: Change from baseline to 12-weeks.

  10. 1 repetition maximum leg press in pounds

    The maximal amount of weight that can be moved with proper

    Time frame: Change from baseline to 12 weeks.

  11. 1 repetition maximum chest press in pounds.

    The maximal amount of weight that can be pushed with proper form.

    Time frame: Change from baseline to 12 weeks.

  12. 30 second sit to stand (optional: in lieu of leg press)

    number of repetitions performed in 30 seconds

    Time frame: Change from baseline to 12 weeks.

  13. Functional Assessment of Cancer Therapy Questionnaire Trial Outcome Index

    The composite score of physical, functional and fatigue subscales of the questionnaire.

    Time frame: Baseline to 12-weeks.

Other outcomes

  1. Physical activity level in minutes per week (average over the previous one month period).

    Godin Leisure Time Questionnaire: minutes of mild, moderate and strenuous exercise.

    Time frame: Change in monthly average physical activity from baseline to one year.

  2. Cost of programming

    costs to programming, institution and participants

    Time frame: one year

  3. Exercise Adherence

    Adherence to exercise programming: attendance at supervised exercise sessions and self-directed sessions over the 1 year period.

    Time frame: Change from baseline to 1 year.

  4. Functional Assessment of Cancer Therapy Fatigue Scale at one year.

    Cancer-related fatigue.

    Time frame: Change from baseline to 1 year.

07

Study locations

1 site
  • University of Alberta/ Cross Cancer Institute
    Edmonton, Alberta T6G 2G4, Canada
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 3, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02647021
Lead sponsor
University of Alberta
Collaborators
Cross Cancer Institute
Responsible party
Margie McNeely (Associate Professor, University of Alberta) — Principal investigator
First posted
Jan 6, 2016
Start date
Mar 31, 2016
Primary completion
Mar 15, 2020
Completion
Mar 30, 2020
Last update
Jan 3, 2024

Study contacts

Margaret L. McNeely, PhD
principal investigator · University of Alberta

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion